The corresponding rates of tumor recurrence in relation to Tg expression in lymph node metastases were 5 out of 15 (33%), 7 out of 15 (46%), 9 out of 21 (42%), and 5 out of 54 (9%) patients (p = 0.002) (Table 3). The gene discussed is TG; the disease is metastatic malignant neoplasm in the lymph nodes.